- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01866787
Study on Baroreceptor Function in Relation to Orthostatic Blood Pressure Regulation After Hip Surgery
Baroreceptor Function and Inflammation in Relation to Orthostatic Intolerance During Early Mobilization After Elective Hip Arthroplasty
The purpose of this observational study is to evaluate the baroreceptor function in relation to surgical inflammation and orthostatic intolerance after elective hip arthroplasty.
The main hypothesis is that baroreceptor function is attenuated after surgery and related to surgical inflammation.
Study Overview
Status
Conditions
Detailed Description
Orthostatic intolerance and hypotension is prevalent during early mobilization after major surgery.
This observational study aims to evaluate the baroreceptor function during using a standardized evaluation protocol before, 6- and 24 hours after elective primary unilateral hip-arthroplasty.
The study hypothesis is that baroreceptor function as expressed by the valsalva ratio is attenuated after surgery and related to surgical inflammation.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Øivind Jans, M.D
- Email: oeivind.jans@regionh.dk
Study Locations
-
-
-
Frederiksberg, Denmark, 2000
- Recruiting
- Frederiksberg Hospital, Department of orthopaedic surgery
-
Contact:
- Arne Borgwardt, M.D.
- Email: Arne.Borgwardt@regionh.dk
-
Principal Investigator:
- Øivind Jans, M.D.
-
Sub-Investigator:
- Kirsten Pors, M.Sci.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Scheduled for unilateral hip arthroplasty
- 18 years or older
- Able to give informed consent
Exclusion Criteria:
- American Society of Anesthesiologists (ASA) class 3 or higher
- Chronic arrythmia (Atrial fibrillation or other arrythmia)
- Incompensated ischaemic heart disease
- Mobilization restriction due to surgical reasons
- Medical complications during admission requiring transferral to other department
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Study cohort
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in baroreceptor function from preoperatively to 6 hours after surgery
Time Frame: 6 hours after surgery
|
Change in baroreceptor function as expressed by change in the blood pressure valsalva ratio during a standardized assessment before and 6 hours after surgery.
|
6 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Orthostatic response in blood pressure
Time Frame: Preoperative, 6 and 24 hours after surgery
|
The response in systolic and diastolic blood pressure during postural change from supine to standing
|
Preoperative, 6 and 24 hours after surgery
|
Orthostatic response in heart rate variability
Time Frame: preoperative, 6 and 24 hours postoperative
|
Heart rate variability during supine rest, sitting and standing as assessed by Spectral analysis.
|
preoperative, 6 and 24 hours postoperative
|
Orthostatic intolerance
Time Frame: preoperative, 6 and 24 hours after surgery
|
Orthostatic intolerance defined as the inability to sit or stand for 3 minutes due to presyncopal symptoms (Dizziness, Nausea, Blurred vision).
|
preoperative, 6 and 24 hours after surgery
|
Inflammatory markers
Time Frame: preoperative, 6 and 24 hours postoperative
|
Inflammatory markers (CRP and interleukin-6) measured at 3 separate timepoint: preoperative, 6- and 24 h after surgery
|
preoperative, 6 and 24 hours postoperative
|
Orthostatic Hypotension
Time Frame: Preoperative, 6 and 24 hours postoperative.
|
orthostatic hypotension defined according to international guidelines.
|
Preoperative, 6 and 24 hours postoperative.
|
Baroreceptor function
Time Frame: On the day of surgery: preoperatively, 6- and 24 hours after surgery
|
baroreceptor function as expressed by change in the blood pressure valsalva ratio during a standardized assessment
|
On the day of surgery: preoperatively, 6- and 24 hours after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Øivind Jans, M.D, Rigshospitalet, Denmark
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RH-4074-OJ3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypotension, Orthostatic
-
James J. Peters Veterans Affairs Medical CenterCompleted
-
H. Lundbeck A/SCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Seoul National University HospitalCompletedOrthostatic; Hypotension, NeurogenicKorea, Republic of
-
Rigshospitalet, DenmarkCompletedPostoperative Orthostatic Hypotension | Postoperative Orthostatic IntoleranceDenmark
-
ShireCompletedSymptomatic Orthostatic HypotensionUnited States, Poland, Czechia, Slovakia
-
Chelsea TherapeuticsCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Hackensack Meridian HealthWithdrawnNeurogenic Orthostatic HypotensionUnited States
-
Seoul National University HospitalKyung Hee University Hospital at GangdongCompletedNeurogenic Orthostatic HypotensionKorea, Republic of
-
National Institute of Neurological Disorders and...Completed
-
Vanderbilt University Medical CenterNYU Langone HealthCompletedNeurogenic Orthostatic HypotensionUnited States